LIfT BioSciences investors increase investment in LIfT and Johnson and Johnson welcomes LIfT into JLABS
Alex Blyth, CEO LIfT BioSciences (@alexblyth33) / Twitter
Alex Blyth on LinkedIn: N-LIfT shows potent cancer killing across multiple solid tumour types
BBC Interview - revolutionary cancer treatment development - Alex Blyth, LIfT BioSciences - YouTube
Investing in the Age of Longevity 2022 – Alex Blyth – LIfT BioSciences - YouTube
LIfT BioSciences, Minaris Regenerative Enter Cell Therapy Partnership | Contract Pharma
Brighton and Hove News » Brighton man who lost his mother to cancer pioneers breakthrough treatment
Alex Blyth on LinkedIn: Hilarious that one of the publications responsible for this make the…
News | LiFTBio Main Site
Team | LiFTBio Main Site
Team | LiFTBio Main Site
Alex Blyth, CEO LIfT BioSciences (@alexblyth33) / Twitter
Team | LiFTBio Main Site
Alex Blyth - CEO at LIfT BioSciences | The Org
LIfT BioSciences gets a double boost
LIfT BioSciences | LinkedIn
Innate Immunity & Mouse Models With LIfT Biosciences' Alex Blyth - YouTube
Team | LiFTBio Main Site
Alex Blyth on LinkedIn: N-LIfT shows potent cancer killing across multiple solid tumour types
Alex Blyth - CEO @ LIfT BioSciences - Crunchbase Person Profile
LIfT BioSciences
Team | LiFTBio Main Site
Minaris and LIfT BioSciences collaborate in cell therapy development - European Biotechnology
Alex Blyth, CEO LIfT BioSciences (@alexblyth33) / Twitter
